Cargando…

Hypoglycemia with gliclazide MR in women with type 2 diabetes. A continuous glucose monitoring study

Detalles Bibliográficos
Autores principales:	Vianna, André G Daher, Tabisz, Laiza, de Lacerda, Claudio Silva, Pechmann, Luciana Muniz, Polesel, Michelle Garcia, Marino, Emerson Cestari, Barreto, Fellype
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653430/ http://dx.doi.org/10.1186/1758-5996-7-S1-A61

Ejemplares similares

Type 2 diabetes: is there any relation between poor control and bone metabolism?
por: Vianna, André G Daher, et al.
Publicado: (2015)

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial
por: Vianna, Andre Gustavo Daher, et al.
Publicado: (2017)

The impact of type 2 diabetes on bone metabolism
por: Sanches, Claudia Pinheiro, et al.
Publicado: (2017)

Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review
por: Mohan, Viswanathan, et al.
Publicado: (2022)

Gliclazide: Unmasking of glucose-6-phosphate dehydrogenase deficiency: case report
Publicado: (2021)

Fabrication and Characterization of Gliclazide Nanocrystals
por: Ravouru, Nagaraju, et al.
Publicado: (2018)

Increased Frequency of Severe Hypoglycemia with the Modified-Release Gliclazide Compared to Glimepiride in Diabetic Older Adults; Propensity Score-Adjusted Analysis
por: Fouad Algendy, Ahmed, et al.
Publicado: (2022)

Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial
por: Leiter, Lawrence A., et al.
Publicado: (2018)

Preparation and Crystallographic Analysis of Gliclazide Polymorphs
por: Rajamma, A. J., et al.
Publicado: (2015)

Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose–insulin homeostasis in animal models
por: Mastan, S K, et al.
Publicado: (2009)

Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
por: Battelino, Tadej, et al.
Publicado: (2011)

The reduction of hypoglycemia among inpatients through a multidisciplinary team work using a PDCA approach
por: Cardim, Thalita Barreira Modena, et al.
Publicado: (2015)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
por: Sampathi, Sunitha, et al.
Publicado: (2022)

Acute Exfoliative Dermatitis/Erythroderma Secondary to Gliclazide
por: Al-Badawi, Saifaldeen, et al.
Publicado: (2023)

Continuous Glucose Monitoring in the Management of Neonates With Persistent Hypoglycemia and Congenital Hyperinsulinism
por: Win, Myat, et al.
Publicado: (2021)

THU276 The Use of Continuous Glucose Monitors for Management of Postbariatric Hypoglycemia
por: Jani, Shivani, et al.
Publicado: (2023)

Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Hypoglycemia Assessed by Continuous Glucose Monitoring Is Associated with Preclinical Atherosclerosis in Individuals with Impaired Glucose Tolerance
por: Castaldo, Ersilia, et al.
Publicado: (2011)

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
por: Hajime, Maiko, et al.
Publicado: (2019)

Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes
por: Choudhary, Pratik, et al.
Publicado: (2013)

Hypoglycemia masquerading as acute psychosis in young age
por: Klemen, P, et al.
Publicado: (2000)

Continuous glucose monitoring in a patient with insulinoma presenting with unawareness of postprandial hypoglycemia
por: Nakajima, Rikako, et al.
Publicado: (2023)

Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
por: Vatsavai, Leela Krishna, et al.
Publicado: (2016)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
por: Kura, Raghunandan Reddy, et al.
Publicado: (2018)

Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles
por: Nasr, Mohamed, et al.
Publicado: (2021)

Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert
por: Puhr, Sarah, et al.
Publicado: (2019)

Hypoglycemia and hyperglycemia in extremely low-birth-weight infants
por: De Carolis, Maria Pia, et al.
Publicado: (2015)

Continuous glucose monitoring for detection of glycemic variability, hypoglycemia, and hyperglycemia in women with eating disorders
por: Uotani, Nao, et al.
Publicado: (2022)

PET/MR attenuation correction in brain imaging using a continuous bone signal derived from UTE
por: Ladefoged, Claes, et al.
Publicado: (2015)

Bioequivalence Study of Modified-Release Gliclazide Tablets in Healthy Volunteers
por: Rojanasthien, Noppamas, et al.
Publicado: (2012)

The influence of physical division of tablets on the variability of release kinetics of gliclazide
por: Wójcik-Pastuszka, Dorota, et al.
Publicado: (2018)

Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
por: Vatsavai, Leela Krishna, et al.
Publicado: (2018)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

High rate of hypoglycemia in diabetic pregnant women on use of glyburide
por: De Bacco, Giordanna, et al.
Publicado: (2015)

Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN
por: Hassanein, Mohamed, et al.
Publicado: (2021)

The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
por: Khunti, Kamlesh, et al.
Publicado: (2023)

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
por: Reddy, Monika, et al.
Publicado: (2018)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

Insulinoma Presenting with Reactive Hypoglycemia: Evaluating the Effect of Tumor Resection via Continuous Glucose Monitoring
por: Kikuchi, Tomohiko, et al.
Publicado: (2017)

Effect of real‐time continuous glucose monitoring on hypoglycemia in adult type 1 diabetes patients
por: Jia, Weiping
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f22cllfl2k3k3e16l15ugjstb7